Skip to main content
Log in

Autonomic testing: which value for each cardiovascular test? An observational study

  • Original Article
  • Published:
Acta Diabetologica Aims and scope Submit manuscript

A Letter to the Editor to this article was published on 08 February 2019

Abstract

Aims

Cardiovascular autonomic testing is time consuming when adopting the entire Ewing battery of tests, hence, clinicians usually adopt an empirically reduced number of tests which may give controversial results. Our purpose was to examine the reliability of the cardiovascular tests most commonly used in autonomic diagnoses.

Methods

We tested 334 subjects, from an original group of 3745, who had shown an altered deep breathing test to both Lying to standing and Valsalva manoeuvre, assuming a value of postural hypotension of more than 15 mmHg as a sign of almost true dysautonomia.

Results

VM showed the highest sensitivity (85%) and, when coupled to LS, highest specificity (83%).

Conclusions

VM could be useful when screening for possible or early autonomic neuropathy, VM + LS is useful as a diagnostic tool for probable or advanced autonomic neuropathy, and VM + LS + PH is useful for certain diagnosis of definite or late stage autonomic neuropathy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Vinik AI, Maser RE, Mitchell BD, Freeman R (2003) Diabetic autonomic neuropathy. Diabetes Care 26:1553–1579

    Article  Google Scholar 

  2. Wheeler T, Watkins PJ (1973) Cardiac denervation in diabetes. Br Med J 8:584–586.

    Article  Google Scholar 

  3. Ewing DJ, Clarke BF (1982) Diagnosis and management of diabetic autonomic neuropahy. Br Med J. 285:916–918

    Article  CAS  Google Scholar 

  4. Bellavere F, Bosello G, Fedele D, Cardone C, Ferri M (1983) Diagnosis and management of diabetic autonomic neuropathy. Br Med J 287:61

    Article  CAS  Google Scholar 

  5. Spallone V, Bellavere F, Scionti L et al (2010) Recommendations for the use of cardiovascular tests in diagnosing diabetic autonomic neuropathy. Nutr Metab Cardiovasc Dis 21:69–78

    Article  Google Scholar 

  6. Bellavere F (1995) Heart rate variability in patients with diabetes and other non cardiological diseases. In: Malik M, Camm AJ (eds) Heart rate variability. Futura Publishing Co., Armonk, pp 507–516

    Google Scholar 

  7. Ewing DJ, Campbell IW, Clarke BF (1976) Mortality in diabetic autonomic neuropathy. Lancet 1:601–603

    Article  PubMed  CAS  Google Scholar 

  8. Pop-Busui R (2010) Cardiac autonomic neuropathy; a clinical perspective. Diabetes Care 33:434–441

    Article  PubMed  PubMed Central  Google Scholar 

  9. Lykke JA, Tarnow L, Parving H-H, Hilsted J (2008) A combined abnormality in heart rate variation and QT corrected interval is a strong predictor of cardiovascular death in type 1 diabetes. Scan J Clin Lab Invest 68:654–659

    Article  CAS  Google Scholar 

  10. Young LH, Wackers FJ, Chyun DA et al (2009) Cardiac outcomes after screening for asymptomatic coronary artery disease in patients with type 2 diabetes. The DIAD study: a randomized controlled trial. J Am Med Assoc 301:1547–1555

    Article  CAS  Google Scholar 

  11. (1983) Editorial: diabetic neuropathy: where are we now? Lancet:1366–1367

  12. Bellavere F, Balzani I, De Masi G et al (1991) Power spectral analysis of heart-rate variations improves assessment of diabetic cardiac autonomic neuropathy. Diabetes 41:633–640

    Article  Google Scholar 

  13. Task force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology (1996) Heart rate variability: standards of measurement, physiological interpretation and clinical use. Circulation 93:1043–1065

    Article  Google Scholar 

  14. Tang ZH, Wang L, Zeng F et al (2014) Bayesian estimation of cardiovascular autonomic neuropathy diagnostic test based on short term heart rate variability without a gold standard. BMJ Open 4(9):e005096

    Article  PubMed  PubMed Central  Google Scholar 

  15. Vinik AI, Ziegler D (2007) Diabetic cardiovascular autonomic neuropathy. Circulation 115:387–397

    Article  PubMed  Google Scholar 

  16. Chyun DA, Wackers FJ, Inzucchi SE et al (2015) Autonomic dysfunction independently predicts poor cardiovascular outcomes in asymptomatic individuals with type 2 diabetes in the DIAD study. SAGE Open Med 3:2050312114568476

    Article  PubMed  PubMed Central  Google Scholar 

  17. Cha SA, Yun JS, Lim TS et al (2016) Diabetic cardiovascular autonomic neuropathy predicts recurrent cardiovascular diseases in patients with type 2 diabetes. PLoS One 11(10):e0164807

    Article  PubMed  PubMed Central  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Giuseppe Bax.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical approval

All procedures followed were in accordance with the institutional guidelines and therefore the ethical standards as laid down in the 1964 Declaration of Helsinki and its later amendments.

Informed consent

Written informed consent was obtained from all the study participants prior to their inclusion in the study.

Additional information

Managed by Antonio Secchi.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Bellavere, F., Ragazzi, E., Chilelli, N.C. et al. Autonomic testing: which value for each cardiovascular test? An observational study. Acta Diabetol 56, 39–43 (2019). https://doi.org/10.1007/s00592-018-1215-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00592-018-1215-y

Keywords

Navigation